Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBasto, R. C.-
dc.contributor.authorAlmeida, J.-
dc.contributor.authorRoque, J. N.-
dc.contributor.authorHenriques, S.-
dc.contributor.authorGonçalves, A. S.-
dc.contributor.authorVaz, F. T.-
dc.contributor.authorCarvalho, H.-
dc.contributor.authorPrieto, I.-
dc.identifier.citationBasto, R. C., Almeida, J., Roque, J. N., Henriques, S., Gonçalves, A. S., Vaz, F. T., Carvalho, H., & Prieto, I. (2023). Clinical outcomes of micropulse transscleral cyclophotocoagulation: 2 years of experience in Portuguese eyes. Journal of Current Glaucoma Practice, 17(1), 30-36.
dc.description.abstractAim: This study evaluates the safety and efficacy of micropulse transscleral cyclophotocoagulation (MPTSCPC) in glaucoma patients, with standard parameters, over a 24-month period. Methods: Retrospective analysis of 61 eyes undergoing MPTSCPC from January 2018 to December 2020 was carried out. Patients received 160 seconds of laser, with settings of 2000 mW/cm2 and a duty cycle of 31.3%. Results: A total of 61 eyes were included, arranged in an age distribution of 73.9 ± 10.8 years. The most frequent diagnosis was primary open-angle glaucoma (POAG), with a mean best-corrected visual acuity (BCVA) of 5/10 in the Snellen Visual chart. Around 37.7% of the eyes had undergone at least one glaucoma filtration surgery prior to MPTSCPC. The mean pretreatment intraocular pressure (IOP) was 24.9 ± 8.6 mm Hg. Except for the contrast at 24 months, at every other follow-up visit, there was a significant reduction (p ≤ 0.001) in IOP and in the number of topical drugs required to control IOP, from four (baseline) to three, with oral acetazolamide suspension in most cases. The total success rate (absolute and clinical successes combined) was 81.9% after 1 year of the treatment. There was no drop in visual acuity or cases of serious complications. There is a positive and significant correlation between prior glaucoma surgery and the need for reinterventions (p = 0.028). Conclusions: Micropulse transscleral cyclophotocoagulation (MPTSCPC) is an effective and safe procedure for reducing IOP within a broad spectrum of glaucoma patients. Additional studies are needed to confirm the current indications, widen their scope, and determine the optimal treatment settings on an individual basis.eng
dc.publisherJaypee Brothers Medical Publishing-
dc.subjectDiode lasereng
dc.subjectGoldmann applanation tonometryeng
dc.subjectIntraocular pressureeng
dc.subjectLaser therapyeng
dc.subjectMicropulse transscleral cyclophotocoagulationeng
dc.subjectRefractory glaucomaeng
dc.subjectTreat and follow-up of glaucomaeng
dc.titleClinical outcomes of micropulse transscleral cyclophotocoagulation: 2 years of experience in Portuguese eyeseng
dc.pagination30 - 36-
dc.subject.fosDomínio/Área Científica::Ciências Médicas::Medicina Básicapor
dc.subject.fosDomínio/Área Científica::Ciências Médicas::Medicina Clínicapor
dc.subject.fosDomínio/Área Científica::Ciências Médicas::Ciências da Saúdepor
iscte.subject.odsSaúde de qualidadepor
iscte.journalJournal of Current Glaucoma Practice-
Appears in Collections:CIES-RI - Artigos em revistas científicas internacionais com arbitragem científica

Files in This Item:
File SizeFormat 
article_95990.pdf406,22 kBAdobe PDFView/Open

FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpaceOrkut
Formato BibTex mendeley Endnote Logotipo do DeGóis Logotipo do Orcid 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.